Your CCSN July 2021 Newsletter is Here

The July 2021 edition of our Newsletter is now available. This issue includes an update on the Patented Medicine Prices Review Board (PMPRB) changes, the Nova Scotia 2021 Election Campaign, a Cancer Can’t-Wait update, upcoming events, and past webinars. Click here to view! Subscribe here for our Newsletter to ensure you receive future editions.

Protect our Access: Update on Changes to the Patent Medicines Pricing Review Board (PMPRB)

The federal government’s plan to push patented drug prices lower continues to meet with controversy. The changes to the regulations governing the Patented Medicine Prices Review Board (PMPRB) have aroused criticism from patient groups and the pharmaceutical industry, which are concerned that the changes will result in fewer life-saving drugs being available in Canada. Rather than being open to dissenting voices and facilitating a constructive

‘A tsunami of cancer’: The need to ramp up care sidelined by COVID-19 is urgent

By Jaimie Roebuck | Republished from Healthy Debate (original article) There is no pause button for cancer. We can’t postpone, hold or reschedule it for a later date. But COVID-19 has forced an abrupt and immediate halt to crucial cancer screening, tests and treatments. While steps have been taken to gradually reintroduce routine and critical cancer care, we need to keep this momentum going –

A Milestone in Lung Cancer Screening

The Canadian Cancer Survivor Network, represented by President & CEO Jackie Manthorne, was pleased to be invited to speak at the Lung Health Foundation’s virtual day at the Ontario Legislature in a celebration of lung cancer screening being made a permanent program in Ontario on May 27, 2021. This event was also attended by Lung Cancer Canada, lung cancer patients, and many Ontario MPPs and

Brain Tumour Incidence and Mortality Report

The Brain Tumour Registry of Canada (BTRC) published their Incidence and Mortality Report on May 26th, 2021. The detailed breakdown of the data and the inclusion of non-malignant tumours make this report uniquely valuable compared to other reporting on brain tumours.

Protect our Access OpEd: COVID vaccine delays illustrate what people dependent on other medicines experience

Canada’s drug review and reimbursement systems are already onerous. It can take from two to five years for some drugs to get to patients. The speed with which we have introduced COVID vaccines shows our government can do much better. Protect our Access is advocating for millions of patients across Canada whose lives depend on medical breakthroughs. READ AND SHARE their recent editorial in Ottawa Citizen